← Back
Data updated: Mar 10, 2026
VITRUVIAS THERAP
Pharmaceuticals
VITRUVIAS THERAP is a generic drug manufacturer with 2 FDA-approved products.
2017
Since
2
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (2)
Company Info
- First Approval
- 2017-09-25
- Latest
- 2018-12-18
- Applications
- 2